Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
As of close of business last night, ProPhase Labs Inc’s stock clocked out at $0.29, up 2.75% from its previous closing price of $0.28. In other words, the price has increased by $2.75 from its previous closing price. On the day, 0.55 million shares were traded. PRPH stock price reached its highest trading level at $0.295 during the session, while it also had its lowest trading level at $0.2608.
Ratios:
To gain a deeper understanding of PRPH’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.33 and its Current Ratio is at 1.47. In the meantime, Its Debt-to-Equity ratio is 0.78 whereas as Long-Term Debt/Eq ratio is at 0.58.
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 20, 2021, initiated with a Buy rating and assigned the stock a target price of $12.
On January 20, 2021, Dawson James started tracking the stock assigning a Buy rating and target price of $25.Dawson James initiated its Buy rating on January 20, 2021, with a $25 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRPH now has a Market Capitalization of 12065340 and an Enterprise Value of 35960344. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.95 while its Price-to-Book (P/B) ratio in mrq is 0.14. Its current Enterprise Value per Revenue stands at 5.312 whereas that against EBITDA is -1.108.
Stock Price History:
The Beta on a monthly basis for PRPH is -0.31, which has changed by -0.9448669 over the last 52 weeks, in comparison to a change of 0.0635103 over the same period for the S&P500. Over the past 52 weeks, PRPH has reached a high of $7.47, while it has fallen to a 52-week low of $0.22. The 50-Day Moving Average of the stock is -24.45%, while the 200-Day Moving Average is calculated to be -80.62%.
Shares Statistics:
It appears that PRPH traded 10.24M shares on average per day over the past three months and 3606310 shares per day over the past ten days. A total of 41.88M shares are outstanding, with a floating share count of 36.97M. Insiders hold about 11.73% of the company’s shares, while institutions hold 5.78% stake in the company. Shares short for PRPH as of 1743379200 were 1187787 with a Short Ratio of 0.12, compared to 1740700800 on 1660683. Therefore, it implies a Short% of Shares Outstanding of 1187787 and a Short% of Float of 3.0700000000000003.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The dynamic stock of ProPhase Labs Inc (PRPH) is currently attracting attention from 1.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is -$0.15, with high estimates of -$0.15 and low estimates of -$0.15.
Analysts are recommending an EPS of between -$0.56 and -$0.56 for the fiscal current year, implying an average EPS of -$0.56.
Revenue Estimates
In the current quarter, 1 analysts expect revenue to total $2.45M. It ranges from a high estimate of $2.45M to a low estimate of $2.45M. As of the current estimate, ProPhase Labs Inc’s year-ago sales were $3.63MFor the next quarter, 1 analysts are estimating revenue of $3.55M. There is a high estimate of $3.55M for the next quarter, whereas the lowest estimate is $3.55M.
A total of 1 analysts have provided revenue estimates for PRPH’s current fiscal year. The highest revenue estimate was $21.36M, while the lowest revenue estimate was $21.36M, resulting in an average revenue estimate of $21.36M. In the same quarter a year ago, actual revenue was $6.8MBased on 1 analysts’ estimates, the company’s revenue will be $41.69M in the next fiscal year. The high estimate is $41.69M and the low estimate is $41.69M.
